PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

A novel translocator protein 18 kDa ligand, ZBD-2, exerts neuroprotective effects against acute spinal cord injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27292096 ↗2016Reported benefit

A novel translocator protein 18 kDa ligand, ZBD-2, exerts neuroprotective effects against acute spinal cord injury.

MouseSpinal cord injuryCompressionC57BL/6Male10 mg/kg (described as high dose; at least one lower dose a…After spinal cord injury

Model: Acute traumatic spinal cord injury induced by spinal cord crush

ZBD-2 at 10 mg/kg improved hindlimb locomotor function, reduced tissue damage and preserved white matter; high-dose ZBD-2 reduced oxidative stress, increased spinal GAD67, raised phosphorylated Akt and lowered the Bax/Bcl-2 ratio, indicating neuroprotection through synaptic and PI3K/Akt mechanisms

Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.